Mira Pharmaceuticals (MIRA) Current Assets (2022 - 2025)
Mira Pharmaceuticals (MIRA) posted Current Assets of $11.1 million for Q4 2025, up 45.54% sequentially from $7.6 million in Q3 2025, and up 282.95% YoY from $2.9 million in Q4 2024.
Mira Pharmaceuticals (MIRA) Current Assets (2022 - 2025) Analysis & Trends
Mira Pharmaceuticals (MIRA) has 4 years of Current Assets data on file, last reported at $11.1 million in Q4 2025.
- Quarterly Current Assets rose 282.95% year-over-year to $11.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $11.1 million (up 282.95% YoY) and the FY2025 annual result came in at $11.1 million, up 282.95% from the prior year.
- Current Assets climbed to $11.1 million in Q4 2025 per MIRA's latest filing, from $7.6 million in the prior quarter.
- The five-year high for Current Assets was $11.1 million in Q4 2025, with the low at $420719.0 in Q2 2023.
- Average Current Assets over 4 years is $4.0 million, with a median of $3.7 million recorded in 2024.
- Year-over-year, Current Assets surged 882.64% in 2023 and tumbled 63.25% in 2025.
- Mira Pharmaceuticals' Current Assets stood at $494405.0 in 2022, then surged by 882.64% to $4.9 million in 2023, then plunged by 40.56% to $2.9 million in 2024, then jumped by 282.95% to $11.1 million in 2025.
- Business Quant data shows MIRA's Current Assets at $11.1 million in Q4 2025, $7.6 million in Q3 2025, and $832879.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 54.84 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 59.17 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 33.53 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | 29.61 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 35.02 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 31.48 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 18.64 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 42.82 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Mira Pharmaceuticals | 22.51 Mn | 11.48 Mn | - | 11.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.06 Mn |
| Sep 30, 2025 | 7.60 Mn |
| Jun 30, 2025 | 832,879.00 |
| Mar 31, 2025 | 1.36 Mn |
| Dec 31, 2024 | 2.89 Mn |
| Sep 30, 2024 | 4.23 Mn |
| Mar 31, 2024 | 3.71 Mn |
| Dec 31, 2023 | 4.86 Mn |
| Sep 30, 2023 | 6.07 Mn |
| Jun 30, 2023 | 420,719.00 |
| Dec 31, 2022 | 494,405.00 |